PDPN+ Tumor Initiating, Treatment Resistant Glioblastoma Cells Promote Radiation Resistance Via PRC2
Aram S. Modrek(New York University), Erik P. Sulman(NYU Langone Health), Floris P Barthel(Translational Genomics Research Institute), Ravesanker Ezhilarasan(Post Graduate Institute of Medical Education and Research), Frederick F. Lang(The University of Texas MD Anderson Cancer Center), Thi Hong Van Le, Kruttika Bhat(University of California, Los Angeles), Kenneth Aldape, Joy Gumin(The University of Texas MD Anderson Cancer Center), Lindsey D. Goodman(Baylor College of Medicine), Q. Wang(Nanjing Medical University), Eskil Eskilsson(The University of Texas MD Anderson Cancer Center), Jinn‐Moon Yang(New York University), Roeland Verhaak(Broad Institute), Ming Tang(Huazhong University of Science and Technology), Lihong Long(The University of Texas MD Anderson Cancer Center)
International Journal of Radiation Oncology*Biology*Physics
October 23, 2020
Cited by 0
Related Papers
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
|Cell|2016|2.4k
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
A pan-cancer proteomic perspective on The Cancer Genome Atlas
|Nature Communications|2014|641